Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia
NCT ID: NCT02419547
Last Updated: 2019-10-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2014-07-31
2015-04-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Data collected during this research study will help electrophysiologists and anesthesiologists to make the best decisions about the best anesthetic conditions to use to perform VT ablations.
This research study is a "pilot" study. Pilot studies are done on a small group of subjects to learn if a larger study would be useful.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiologically Guided VT Ablation
NCT04004624
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
NCT01013714
Functional Substrate-Only Guided VT Ablation
NCT06464315
Late Potentials and Ablation Index in Ventricular Tachycardia Ablation
NCT03437408
Non-invasive Ablation of Ventricular Tachycardia
NCT03601832
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anesthesia Induction
Patients undergoing ventricular tachycardia ablation will undergo programmed stimulation (PS) with minimal sedation (Versed, Fentanyl), with intravenous agents (propofol) , and finally with volatile inhalational agent (sevoflurane).
Versed
Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia
Fentanyl
Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia
Propofol
Phase 2: Standard induction of GETA with intravenous agent then programed stimulation to induce ventricular tachycardia
Sevoflurane
Phase 3: Standard induction of GETA with inhalent agent then programed stimulation to induce ventricular tachycardia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Versed
Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia
Fentanyl
Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia
Propofol
Phase 2: Standard induction of GETA with intravenous agent then programed stimulation to induce ventricular tachycardia
Sevoflurane
Phase 3: Standard induction of GETA with inhalent agent then programed stimulation to induce ventricular tachycardia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients 18 years of age or older
Exclusion Criteria
* Women who are pregnant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Douglas Shook
Chief, Divison of Cardiac Anesthesia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wendy L Gross, M.D.
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brigahm and Women's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-P-000241
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.